113 related articles for article (PubMed ID: 3005960)
1. [Effect of combined radiotherapy, hyperthermia, radioprotective agent and hypoxic cell sensitizer on mice testis--testicular weight as indicator of the combined effect].
Nakano Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1152-66. PubMed ID: 3005960
[No Abstract] [Full Text] [Related]
2. Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
Mendiondo OA; Grigsby PW; Beach JL
Radiology; 1983 Jul; 148(1):291-3. PubMed ID: 6304811
[TBL] [Abstract][Full Text] [Related]
3. [Responses to radiation of Ehrlich ascites tumor cells in the presence of YM-08310 (=WR-2721) and/or Ro-07-0582 (in vivo, in vitro assay)].
Ebe K
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Feb; 47(2):307-17. PubMed ID: 3039456
[No Abstract] [Full Text] [Related]
4. Mechanism of unusual cell enlargement in the testis of irradiated mouse following treatment with a radioprotective thiophosphate.
Jaimala ; Bhartiya HC
Radiobiol Radiother (Berl); 1988; 29(4):429-33. PubMed ID: 2847226
[No Abstract] [Full Text] [Related]
5. Inhibition of reduction in the testicular weight by WR-2721 in relation to the body weight after whole-body gamma irradiation.
Bhartiya HC; Jaimala
Strahlenther Onkol; 1986 Jan; 162(1):68-70. PubMed ID: 3003944
[TBL] [Abstract][Full Text] [Related]
6. [Radioprotective effects of YM-08310 on normal and malignant tissues (author's transl)].
Tsukiyama I
Nihon Igaku Hoshasen Gakkai Zasshi; 1978 Sep; 38(9):888-902. PubMed ID: 213767
[No Abstract] [Full Text] [Related]
7. [Combined use of amifostine and misonidazole in experimental radiotherapy].
Tsukiyama I
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Apr; 43(4):613-21. PubMed ID: 6310492
[No Abstract] [Full Text] [Related]
8. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].
Tanaka Y; Akagi K; Hasegawa T; Nakazawa M; Harima K; Murata T; Sawada S
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):700-9. PubMed ID: 6312407
[No Abstract] [Full Text] [Related]
9. Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.
Grigsby P; Maruyama Y
Br J Radiol; 1981 Nov; 54(647):969-72. PubMed ID: 6272925
[TBL] [Abstract][Full Text] [Related]
10. Radioprotective effect of WR-2721 on haematopoiesis in mice. I. Quantitative changes in haematopoiesis.
Brezáni P; Macková N
Radiobiol Radiother (Berl); 1988; 29(5):587-93. PubMed ID: 2852382
[No Abstract] [Full Text] [Related]
11. Radioprotective effect of WR-2721 on haematopoiesis in mice. III. Changes in peripheral blood.
Macková N; Brezáni P
Radiobiol Radiother (Berl); 1988; 29(5):603-8. PubMed ID: 2852384
[No Abstract] [Full Text] [Related]
12. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
Milas L; Hunter N; Reid BO; Thames HD
Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
[TBL] [Abstract][Full Text] [Related]
13. Radioprotective effect of WR-2721 in rabbits: a comparison with cystamine.
Kuna P; Petýrek P; Jensovský V; Melek J
Radiobiol Radiother (Berl); 1981; 22(5):644-52. PubMed ID: 6280232
[No Abstract] [Full Text] [Related]
14. Radioprotective effect of WR-2721 on haematopoiesis in mice. II. Morphological changes of bone marrow and spleen.
Macková N; Brezáni P
Radiobiol Radiother (Berl); 1988; 29(5):595-601. PubMed ID: 2852383
[No Abstract] [Full Text] [Related]
15. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
[No Abstract] [Full Text] [Related]
16. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
17. Time dependence of interaction of misonidazole and WR-2721.
Rojas A; Denekamp J
Br J Radiol; 1983 Aug; 56(668):592-5. PubMed ID: 6307457
[No Abstract] [Full Text] [Related]
18. [Effect of pharmacological agents on the radioprotective activity, toxicity and distribution of 35S-labeled aminopropylaminoethyl-thiophosphate administered perorally].
Grechka II; Belavina LP; Kalistratov GV; Zherebchenko PG
Radiobiologiia; 1979; 19(3):372-6. PubMed ID: 223190
[No Abstract] [Full Text] [Related]
19. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Ohizumi Y; Murayama C; Maezawa H; Mori T
Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
[TBL] [Abstract][Full Text] [Related]
20. Sodium hydrogen-S-(3-amino-2-hydroxypropyl) phosphorothioate (WR-77913): toxicity and bone marrow radioprotection.
Mendiondo OA; Connor AM; Grigsby P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):553-5. PubMed ID: 6286552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
